Vanda Pharmaceuticals shares owned by Ameriprise Financial
Quarter-by-quarter ownership of Vanda Pharmaceuticals (VNDA) shares owned by Ameriprise Financial
from 13F filings
Historical chart of Ameriprise Financial investment in Vanda Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Vanda Pharmaceuticals held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Vanda Pharmaceuticals by Ameriprise Financial
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $1.1M | 242k | 4.69 |
2024-06-30 | $1.4M | 244k | 5.65 |
2024-03-31 | $1.0M | 244k | 4.11 |
2023-09-30 | $2.7M | 630k | 4.32 |
2023-06-30 | $7.0M | 1.1M | 6.59 |
2023-03-31 | $6.7M | 991k | 6.79 |
2022-12-31 | $6.2M | 842k | 7.39 |
2022-09-30 | $9.0M | 912k | 9.88 |
2022-06-30 | $8.5M | 782k | 10.90 |
2022-03-31 | $9.0M | 799k | 11.31 |
2021-12-31 | $12M | 759k | 15.69 |
2021-09-30 | $6.5M | 377k | 17.14 |
2021-06-30 | $7.9M | 368k | 21.51 |
2021-03-31 | $5.1M | 336k | 15.02 |
2020-12-31 | $5.2M | 393k | 13.14 |
2020-09-30 | $4.4M | 460k | 9.66 |
2020-06-30 | $4.2M | 367k | 11.44 |
2020-03-31 | $3.9M | 372k | 10.36 |
2019-12-31 | $5.8M | 355k | 16.41 |
2019-09-30 | $4.8M | 360k | 13.28 |
2019-06-30 | $5.4M | 384k | 14.09 |
2019-03-31 | $8.3M | 454k | 18.40 |
2018-12-31 | $16M | 628k | 26.13 |
2018-09-30 | $4.6M | 202k | 22.95 |
2018-06-30 | $2.1M | 108k | 19.05 |
2018-03-31 | $1.7M | 98k | 16.85 |
2017-12-31 | $1.3M | 88k | 15.20 |
2017-09-30 | $1.6M | 88k | 17.90 |
2017-06-30 | $1.4M | 88k | 16.30 |
2014-12-31 | $1.9M | 134k | 14.32 |
2014-09-30 | $630k | 61k | 10.39 |
2014-06-30 | $6.0k | 350 | 17.14 |
2014-03-31 | $83k | 5.1k | 16.18 |
2013-12-31 | $474k | 38k | 12.40 |
2013-09-30 | $974k | 89k | 10.98 |
2012-06-30 | $8.0k | 1.8k | 4.45 |
2011-06-30 | $253k | 34k | 7.39 |
2011-03-31 | $258k | 34k | 7.52 |